NP

Nandan Pejavar Rao

Active Director Director DIN 08262013
DIN 08262013 First appointment Oct 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Oct 2018
Shareholding value •••• Premium profile

About Nandan Pejavar Rao

Data last updated:

Nandan Pejavar Rao is a Director at Remidex Pharma Private Limited (since 2018), Director at Ishaan Labs Private Limited (since 2018) and Director at Sanil Pharmaceuticals Private Limited (since 2018), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹24.75 Cr; the largest is Remidex Pharma Private Limited at ₹24.55 Cr (FY 2025). Earlier, Nandan Pejavar Rao was a Director at Alleviative Health Solutions Private Limited (from 2023).

DIN 08262013
Primary Designation Director
Industry Pharma
First Appointment 24 Oct 2018
Oldest Company Age 45 yrs
Largest company Remidex Pharma Private Limited · ₹24.55 Cr (FY 2025)
Combined revenue ₹24.75 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remidex Pharma Private Limited U24231KA1981PTC004260
Director24 Oct 20181981₹24.55 Cr (FY 2025)Active
Ishaan Labs Private Limited U24233KA1995PTC018262
Director24 Oct 20181995₹10.5 Lakh (FY 2025)Active
Director24 Oct 20181989₹9.5 Lakh (FY 2025)Active
Designated Partner27 Jan 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Aug 20232023Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Nandan Pejavar Rao

Directorship timeline

Open interactive timeline →
Remidex Pharma Private Limited
Sanil Pharmaceuticals Private Limited
Ishaan Labs Private Limited
Surima Ventures Llp
Premium access

Shareholding and investment profile for Nandan Pejavar Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nandan Pejavar Rao

Nandan Pejavar Rao currently holds 4 directorships: Remidex Pharma Private Limited (Director, since 24 Oct 2018, revenue ₹24.55 Cr (FY 2025)); Ishaan Labs Private Limited (Director, since 24 Oct 2018, revenue ₹10.5 Lakh (FY 2025)); Sanil Pharmaceuticals Private Limited (Director, since 24 Oct 2018, revenue ₹9.5 Lakh (FY 2025)); Surima Ventures Llp (Designated Partner, since 27 Jan 2025).

Nandan Pejavar Rao was first appointed on 24 Oct 2018 as Director at Remidex Pharma Private Limited. The most recent appointment on record is 27 Jan 2025 at Surima Ventures Llp.

The 3 current companies of Nandan Pejavar Rao that report revenue have a combined latest revenue of ₹24.75 Cr: Remidex Pharma Private Limited ₹24.55 Cr (FY 2025); Ishaan Labs Private Limited ₹10.5 Lakh (FY 2025); Sanil Pharmaceuticals Private Limited ₹9.5 Lakh (FY 2025).

Nandan Pejavar Rao held 1 earlier board appointment: Alleviative Health Solutions Private Limited (Director, from 08 Aug 2023).

The current boards of Nandan Pejavar Rao's companies include Ishaan Pejavar Rao (Remidex Pharma Private Limited), Nilima Dayanand Rao (Remidex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available